Eticovo is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Samsung Bioepis Co., Ltd.. The primary component is Etanercept.
Product ID | 71202-003_d2d6f14e-fdc3-46ab-b84b-4b17d3bea8f0 |
NDC | 71202-003 |
Product Type | Human Prescription Drug |
Proprietary Name | Eticovo |
Generic Name | Etanercept |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2020-10-31 |
Marketing Category | BLA / |
Application Number | BLA761066 |
Labeler Name | Samsung Bioepis Co., Ltd. |
Substance Name | ETANERCEPT |
Active Ingredient Strength | 50 mg/mL |
Pharm Classes | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
NDC | Brand Name | Generic Name |
---|---|---|
50090-3531 | ENBREL | etanercept |
50090-4490 | ENBREL | etanercept |
50090-4590 | ENBREL | etanercept |
58406-010 | ENBREL | etanercept |
58406-021 | ENBREL | etanercept |
58406-032 | ENBREL | etanercept |
58406-044 | ENBREL | etanercept |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ETICOVO 88250039 not registered Live/Pending |
Samsung Bioepis Co., Ltd. 2019-01-04 |